￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Nilotinib (Nilotinib) domestic launch time and access methods

2026-02-01 22:25:32

Check Details
Recommended daily dosage and treatment regimen of Revumenib

2026-02-01 22:25:32

Check Details
Zenocutuzumab clinical trials show whether efficacy is stable

2026-02-01 22:25:32

Check Details
What are the adverse reactions of Cosibelimab?

2026-02-01 22:25:32

Check Details
What types of lung cancer patients does Ensartinib mainly treat?

2026-02-01 22:25:32

Check Details
What type of new anti-cancer drug does Datopotamab belong to?

2026-02-01 22:25:32

Check Details
Precautions during use of Mirdametinib

2026-02-01 22:25:32

Check Details
What are the contraindications that require special attention when using Vimseltinib?

2026-02-01 22:25:32

Check Details
How long does it take to take a complete course of Atrasentan?

2026-02-01 22:25:32

Check Details
Summary of real medication experience and feedback from patients with Telisotuzumab

2026-02-01 22:25:32

Check Details
How to deal with side effects of sunitinib

2026-02-01 22:25:32

Check Details
What is the approximate market price of the generic version of tazerestat?

2026-02-01 22:25:32

Check Details
Category
相关知识